Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Moderna, Baxter, and Pfizer are our top healthcare picks.

There’s no question, however, that the decision to abandon the twice-daily version introduces a significant delay to Pfizer’s plans to enter the obesity market, which has been transformed in ...

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

A cluster of high-tech plants offering well-paid jobs has transformed Carrigtwohil, quadrupling its population in just two ...

Dansey was chief medical officer of ADC specialist Seagen, which Pfizer acquired for $43 billion last year, and he plans to retire ... referencing a disappointing obesity programme.

As US President Donald Trump takes aim at the mostly American-owned pharmaceutical factories that dot the Irish countryside, ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Martin Pomper, MD, PhD, is Professor of Radiology at the University of Texas Southwestern Medical Center and holds the Effie and Wofford Cain Distinguished Chair in Diagnostic Imaging. Dr. Pomper's ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...